Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldgar

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
Journal of Medical Genetics|August 15, 2006
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerJacques Simard, Martine Dumont, Anne-Marie Moisan, et al.
Gastroenterology|November 18, 2008
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndromeJuul T Wijnen, Richard M Brohet, Ronald van Eijk, et al.
Nature Genetics|January 27, 2009
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathwaysRajan P Nair, Kristina Callis Duffin, Cynthia Helms, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Nature Genetics|April 23, 2002
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsHanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
JNCI Cancer Spectrum|March 16, 2019
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With <i>BRCA1</i> or <i>BRCA2</i> MutationsMary Beth Terry, Yuyan Liao, Karin Kast, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
Journal of Medical Genetics|August 15, 2006
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerJacques Simard, Martine Dumont, Anne-Marie Moisan, et al.
Gastroenterology|November 18, 2008
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndromeJuul T Wijnen, Richard M Brohet, Ronald van Eijk, et al.
Nature Genetics|January 27, 2009
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathwaysRajan P Nair, Kristina Callis Duffin, Cynthia Helms, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Nature Genetics|April 23, 2002
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsHanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
JNCI Cancer Spectrum|March 16, 2019
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With <i>BRCA1</i> or <i>BRCA2</i> MutationsMary Beth Terry, Yuyan Liao, Karin Kast, et al.
Pageof 8